about
Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress DisordersThe GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats.Increased Serotonin Transporter Expression Reduces Fear and Recruitment of Parvalbumin Interneurons of the Amygdala.Social defeat: impact on fear extinction and amygdala-prefrontal cortical theta synchrony in 5-HTT deficient miceNeurological effects of honey: current and future prospects.Comorbidity of mood and anxiety disorders.Anxiety and Depression: Optimizing Treatments.Mental disorders in primary careModeling anxiety using adult zebrafish: a conceptual review.The serotonin transporter gene polymorphism and the effect of baseline on amygdala response to emotional facesEnhanced anger superiority effect in generalized anxiety disorder and panic disorder.Anxiety and orienting of gaze to angry and fearful faces.Memantine as an augmentation therapy for anxiety disorders.Escitalopram in obsessive-compulsive disorder: a case series.Emerging anxiolytics.Neuroimaging studies of pediatric social anxiety: paradigms, pitfalls and a new direction for investigating the neural mechanisms.The hormonal control of ejaculation.Separate and combined effects of genetic variants and pre-treatment whole blood gene expression on response to exposure-based cognitive behavioural therapy for anxiety disorders.A Proposed Algorithm for Improved Recognition and Treatment of the Depression/Anxiety Spectrum in Primary Care.Managing psychiatric disorders in primary care: 2. Anxiety.Acamprosate calcium as augmentation therapy for anxiety disorders.Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior.Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background.Efficacy of cognitive behaviour therapy in generalized anxiety disorders. Results of a controlled clinical trial (Berlin CBT-GAD Study).
P2860
Q21144229-7AD9F3E4-5789-4372-AA06-74287C07C209Q22305681-05D4377C-192A-4EF0-B2BD-DCB9B03B6ABDQ27305120-C67E21B7-F92E-4D49-839D-8407DAF1549DQ27310831-9B5BC53E-5246-44C6-BF93-4D5389AC1E4CQ27330230-F4AE2604-799C-4454-90D1-51FC57A5F055Q33608588-C5FDB28F-E9C6-44D6-B6BA-84C7CB6B1C21Q34093719-6049DC01-8521-4AD1-8991-704181E4E772Q34304950-91CF0A30-9277-4726-83FF-1D0FB8FF74C4Q35236313-9FC1FA05-7A78-430F-99A9-3313A0D85681Q35375608-EC34C92F-F0E0-46DA-B6CF-E855E1E587D7Q35532160-A4DE87EE-0AA5-4FF1-AAFF-5B3DDC9C1AD8Q35752071-C34FA6E1-3B53-4DAA-8EB7-CB3415720B38Q36138171-0F413491-CFE1-4A55-8F01-C9EEE048DD64Q36169059-B2AA77A4-EF06-4D6D-97E5-A24411526DD3Q36274266-EE921C27-B6F8-4F52-B87E-77DDDF49AEDBQ36989910-A6072698-A8F1-46CD-9FD7-FD08EE1F9378Q37071423-E2B45392-F952-44D4-B3ED-2F22AC0F2FA2Q38032479-4A7C33E6-8A22-4D74-9BE7-F8B46E0F5555Q38845473-9BB9FE46-9700-433A-81A3-6856C32D3D4DQ39853665-F4542B04-6614-45A0-B4B2-718D7739ED71Q41751296-D8C40FE7-684D-4303-B436-7DBCFC89E452Q42825707-35DE1F00-D8CE-4ECE-A4E5-BBA8ECFAE743Q44580922-8694B7EF-43D7-41E0-A6C3-9FE0674AF8DCQ44678361-EFEA23F9-14C5-4ABB-AB9F-40E9F6AE5345Q51934362-946FC32E-5810-466B-9B3E-72B60953E900
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Current treatments of the anxiety disorders in adults.
@ast
Current treatments of the anxiety disorders in adults.
@en
type
label
Current treatments of the anxiety disorders in adults.
@ast
Current treatments of the anxiety disorders in adults.
@en
prefLabel
Current treatments of the anxiety disorders in adults.
@ast
Current treatments of the anxiety disorders in adults.
@en
P1476
Current treatments of the anxiety disorders in adults.
@en
P2093
Ballenger JC
P304
P356
10.1016/S0006-3223(99)00220-6
P407
P577
1999-12-01T00:00:00Z